Bioactivity of albumins bound to silver nanoparticles.
The last decade has witnessed a tremendous rise in the proposed applications of nanomaterials in the field of medicine due to their very attractive physiochemical properties and novel actions such as the ability to reach previously inaccessible targets such as brain. However biological activity of functional molecules bound to nanoparticles and its physiological consequences is still unclear and hence this area requires immediate attention. The functional properties of Human Serum Albumin (HSA) and Bovine Serum Albumin (BSA) bound to silver nanoparticles (~60 nm) have been studied under physiological environment. Esterase activity, binding of drugs (warfarin and ibuprofen), antioxidant activity and copper binding by albumins was evaluated. The catalytic efficiencies of HSA and BSA diminished upon binding to silver nanoparticles. Perturbation in binding of warfarin and ibuprofen, loss of free sulphydryls, antioxidant activity and enhancement of copper binding were observed in albumins bound to nanoparticles. These alterations in functional activity of nanoparticle bound albumins which will have important consequences should be taken into consideration while using nanoparticles for diagnostic and therapeutic purposes.
Department of Biophysics, University of Mumbai, Vidyanagari, Santacruz (E), Mumbai, 400 098, India.
Jessy
J
Mariam
S
S
Sivakami
D C
DC
Kothari
P M
PM
Dongre
D000418:Albumins / Q000737:chemistry* / Q000378:metabolism*; D000578:Amidines; D000818:Animals; D002417:Cattle; D003300:Copper / Q000737:chemistry / Q000378:metabolism; D004950:Esterases; D006801:Humans; D053768:Metal Nanoparticles / Q000737:chemistry*; D053758:Nanoparticles / Q000378:metabolism*; D011485:Protein Binding; D012710:Serum Albumin, Bovine; D012834:Silver / Q000737:chemistry* / Q000378:metabolism*
D000418:Albumins; D000578:Amidines; D012710:Serum Albumin, Bovine; D012834:Silver; C046728:2,2'-azobis(2-amidinopropane); D003300:Copper; D004950:Esterases